sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide

C95H104BrI3N19NaO10Zn — CID 157453359

IUPACsodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide
SMILESCC(C)I.COC(=O)c1cc(-c2ccc(C)cn2)c2cnn(C(C)C)c2c1.COC(=O)c1cc(I)c2cn[nH]c2c1.COC(=O)c1cc(I)c2cnn(C(C)C)c2c1.Cc1cc[c-]nc1.Cc1ccc(-c2cc(C(=O)CCc3cnc(C)cn3)cc3c2cnn3C(C)C)nc1.Cc1ccc(-c2cc(C(=O)O)cc3c2cnn3C(C)C)nc1.Cc1cnc(CN)cn1.[Na+].[OH-].[Zn+]Br
InChIInChI=1S/C24H25N5O.C18H19N3O2.C17H17N3O2.C12H13IN2O2.C9H7IN2O2.C6H9N3.C6H6N.C3H7I.BrH.Na.H2O.Zn/c1-15(2)29-23-10-18(24(30)8-6-19-13-25-17(4)12-26-19)9-20(21(23)14-28-29)22-7-5-16(3)11-27-22;1-11(2)21-17-8-13(18(22)23-4)7-14(15(17)10-20-21)16-6-5-12(3)9-19-16;1-10(2)20-16-7-12(17(21)22)6-13(14(16)9-19-20)15-5-4-11(3)8-18-15;1-7(2)15-11-5-8(12(16)17-3)4-10(13)9(11)6-14-15;1-14-9(13)5-2-7(10)6-4-11-12-8(6)3-5;1-5-3-9-6(2-7)4-8-5;1-6-3-2-4-7-5-6;1-3(2)4;;;;/h5,7,9-15H,6,8H2,1-4H3;5-11H,1-4H3;4-10H,1-3H3,(H,21,22);4-7H,1-3H3;2-4H,1H3,(H,11,12);3-4H,2,7H2,1H3;2-3,5H,1H3;3H,1-2H3;1H;;1H2;/q;;;;;;-1;;;+1;;+2/p-2
InChIKeyAKDUVZBJGLLHBG-UHFFFAOYSA-L
MW2221.00 g/mol
LogP18.26
Rot. Bonds16

About sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide

sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide (PubChem CID 157453359) has the molecular formula C95H104BrI3N19NaO10Zn and a molecular weight of 2221.00 g/mol. Its IUPAC name is sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide.

Molecular Properties

Compound Namesodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide
PubChem CID157453359
Molecular FormulaC95H104BrI3N19NaO10Zn
Molecular Weight2221.00 g/mol
Exact Mass2217.37
IUPAC Namesodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide
SMILESCC(C)I.COC(=O)c1cc(-c2ccc(C)cn2)c2cnn(C(C)C)c2c1.COC(=O)c1cc(I)c2cn[nH]c2c1.COC(=O)c1cc(I)c2cnn(C(C)C)c2c1.Cc1cc[c-]nc1.Cc1ccc(-c2cc(C(=O)CCc3cnc(C)cn3)cc3c2cnn3C(C)C)nc1.Cc1ccc(-c2cc(C(=O)O)cc3c2cnn3C(C)C)nc1.Cc1cnc(CN)cn1.[Na+].[OH-].[Zn+]Br
InChIInChI=1S/C24H25N5O.C18H19N3O2.C17H17N3O2.C12H13IN2O2.C9H7IN2O2.C6H9N3.C6H6N.C3H7I.BrH.Na.H2O.Zn/c1-15(2)29-23-10-18(24(30)8-6-19-13-25-17(4)12-26-19)9-20(21(23)14-28-29)22-7-5-16(3)11-27-22;1-11(2)21-17-8-13(18(22)23-4)7-14(15(17)10-20-21)16-6-5-12(3)9-19-16;1-10(2)20-16-7-12(17(21)22)6-13(14(16)9-19-20)15-5-4-11(3)8-18-15;1-7(2)15-11-5-8(12(16)17-3)4-10(13)9(11)6-14-15;1-14-9(13)5-2-7(10)6-4-11-12-8(6)3-5;1-5-3-9-6(2-7)4-8-5;1-6-3-2-4-7-5-6;1-3(2)4;;;;/h5,7,9-15H,6,8H2,1-4H3;5-11H,1-4H3;4-10H,1-3H3,(H,21,22);4-7H,1-3H3;2-4H,1H3,(H,11,12);3-4H,2,7H2,1H3;2-3,5H,1H3;3H,1-2H3;1H;;1H2;/q;;;;;;-1;;;+1;;+2/p-2
InChIKeyAKDUVZBJGLLHBG-UHFFFAOYSA-L
XLogP18.26
TPSA392.37 Ų
H-Bond Donors3
H-Bond Acceptors27
Rotatable Bonds16
Heavy Atoms130
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002221.00
LogP ≤ 518.26
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

ethyl acetate;ethyl 9-methylpyrido[3,4-b]indole-3-carboxylate;ethyl 3-(9-methylpyrido[3,4-b]indol-3-yl)-3-oxopropanoate;ethyl 9H-pyrido[3,4-b]indole-3-carboxylate;iodomethane;1-(9-methylpyrido[3,4-b]indol-3-yl)butane-1,3-dione;1-(9-methylpyrido[3,4-b]indol-3-yl)ethanone;9-methyl-3-[5-(trifluoromethyl)-1H-pyrazol-3-yl]pyrido[3,4-b]indole
CID 158126392
4-[4-(2-amino-4-oxopent-2-en-3-yl)-2-[[phenyl(pyridin-2-yl)methyl]amino]benzenecarboximidoyl]benzoic acid;2-[4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[phenyl(pyridin-2-yl)methyl]indazol-3-yl]phenyl]acetic acid;methyl 2-[4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[phenyl(pyridin-2-yl)methyl]indazol-3-yl]phenyl]acetate;methyl 4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1S)-1-pyridin-2-ylethyl]indazol-3-yl]benzoate
CID 157207684
sodium;methane;methyl 4-(5-methyl-2-pyridinyl)-1H-indazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-phenylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-phenylindazole-6-carboxamide;4-(5-methyl-2-pyridinyl)-1-phenylindazole-6-carboxylic acid;hydroxide
CID 158824967
1,2-diiodo-2-methylpropane;N,5-dipyridin-3-yl-1H-indazole-3-carboxamide;iodoethane;2-iodo-2-methanidylpropane;2-iodo-2-methylpropane;5-iodo-1-(oxan-2-yl)indazole-3-carbaldehyde;1-(oxan-2-yl)-N,5-dipyridin-3-ylindazole-3-carboxamide;1-(oxan-2-yl)-5-pyridin-3-ylindazole-3-carbaldehyde;1-(oxan-2-yl)-5-pyridin-3-ylindazole-3-carboxylic acid;pyridin-3-amine;pyridin-3-ylboronic acid;1,1,2-triiodo-2-methylpropane;bis(vanadium)
CID 158995778
7-(1,3-dimethylpyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;methyl 3-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrrole-2-carboxylate;2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)pyrazol-1-yl]ethanol;7-(2H-triazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine
CID 159270967
5-[3-[3-(4-carboxyphenyl)propanoyl]-1-methylpyrazol-5-yl]-1H-indole-2-carboxylic acid;1-[5-[2-(ethoxymethyl)-1H-indol-5-yl]-1-methylpyrazol-3-yl]-3-pyridin-4-ylpropan-1-one;ethyl 5-[1-methyl-3-[3-(4-oxocyclohexa-1,5-dien-1-yl)propanoyl]pyrazol-5-yl]-1H-indole-2-carboxylate;ethyl 5-[1-methyl-3-(3-pyridin-4-ylpropanoyl)pyrazol-5-yl]-1H-indole-2-carboxylate;ethyl 5-[5-methyl-2-(3-pyridin-4-ylpropanoyl)-4-pyridinyl]-1H-indole-2-carboxylate;ethyl 5-[5-(3-pyridin-4-ylpropanoyl)-3-pyridinyl]-1H-indole-2-carboxylate;3-pyridin-4-yl-1-[3-(2-pyridin-4-yl-1H-indol-5-yl)phenyl]propan-1-one
CID 159571012
(1E,3Z)-buta-1,3-diene-1,2,4-triamine;2-chloro-4-iodopyridine;5-[(2-chloro-4-pyridinyl)methyl]-1H-isoindole;5-[4-(1H-indazol-5-ylmethyl)-2-pyridinyl]-1H-indole-2-carboxylic acid;1-[5-[4-(1H-indazol-5-ylmethyl)-2-pyridinyl]-1H-indol-2-yl]-2-pyridazin-4-ylethanone;1H-isoindol-5-amine;methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indene-2-carboxylate
CID 159571485
sodium;(2S)-2-aminopropan-1-ol;bromozinc(1+);(3R)-4-hydroxy-3-methyl-1-[3-(2-methylpropyl)-7-(5-methyl-2-pyridinyl)benzimidazol-5-yl]butan-1-one;1-iodo-2-methylpropane;methyl 7-iodo-3H-benzimidazole-5-carboxylate;methyl 4-iodo-1-(2-methylpropyl)indazole-6-carboxylate;methyl 3-(2-methylpropyl)-7-(5-methyl-2-pyridinyl)benzimidazole-5-carboxylate;3-(2-methylpropyl)-7-(5-methyl-2-pyridinyl)benzimidazole-5-carboxylic acid;5-methyl-2H-pyridin-2-ide;hydroxide
CID 159697247
tert-butyl 3-[7-(4-methoxycarbonylphenyl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrrolidine-1-carboxylate;tert-butyl 3-[7-[4-(2-pyridin-2-ylacetyl)phenyl]-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrrolidine-1-carboxylate;4-[5-[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]-1H-pyrazolo[3,4-c]pyridin-7-yl]benzoic acid;1-[3-[7-[4-(2-pyridin-2-ylacetyl)phenyl]-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrrolidin-1-yl]prop-2-en-1-one;2-pyridin-2-yl-1-[4-(5-pyrrolidin-3-yl-1H-pyrazolo[3,4-c]pyridin-7-yl)phenyl]ethanone
CID 159824817
sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide
CID 161160102
4-[5-(2-amino-4-oxopent-2-en-3-yl)-3-[[phenyl(pyridin-2-yl)methyl]amino]pyridine-2-carboximidoyl]benzoic acid;1-[4-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[[(1S)-1-pyridin-2-ylethyl]amino]pyridine-2-carboximidoyl]phenyl]propan-2-one;4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1S)-1-pyridin-2-ylethyl]pyrazolo[4,3-b]pyridin-3-yl]benzoic acid;methyl 4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1S)-1-pyridin-2-ylethyl]pyrazolo[4,3-b]pyridin-3-yl]benzoate
CID 161242059
sodium;methyl 4-(5-methyl-2-pyridinyl)-1H-indazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-phenylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-phenylindazole-6-carboxamide;4-(5-methyl-2-pyridinyl)-1-phenylindazole-6-carboxylic acid;hydroxide
CID 161755687

Frequently Asked Questions

What is the IUPAC name of sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide?
The IUPAC name of sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide (CID 157453359) is sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide.
What is the SMILES notation for sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide?
The canonical SMILES for sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide is CC(C)I.COC(=O)c1cc(-c2ccc(C)cn2)c2cnn(C(C)C)c2c1.COC(=O)c1cc(I)c2cn[nH]c2c1.COC(=O)c1cc(I)c2cnn(C(C)C)c2c1.Cc1cc[c-]nc1.Cc1ccc(-c2cc(C(=O)CCc3cnc(C)cn3)cc3c2cnn3C(C)C)nc1.Cc1ccc(-c2cc(C(=O)O)cc3c2cnn3C(C)C)nc1.Cc1cnc(CN)cn1.[Na+].[OH-].[Zn+]Br.
What is the InChIKey of sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide?
The InChIKey is AKDUVZBJGLLHBG-UHFFFAOYSA-L. The full InChI is InChI=1S/C24H25N5O.C18H19N3O2.C17H17N3O2.C12H13IN2O2.C9H7IN2O2.C6H9N3.C6H6N.C3H7I.BrH.Na.H2O.Zn/c1-15(2)29-23-10-18(24(30)8-6-19-13-25-17(4)12-26-19)9-20(21(23)14-28-29)22-7-5-16(3)11-27-22;1-11(2)21-17-8-13(18(22)23-4)7-14(15(17)10-20-21)16-6-5-12(3)9-19-16;1-10(2)20-16-7-12(17(21)22)6-13(14(16)9-19-20)15-5-4-11(3)8-18-15;1-7(2)15-11-5-8(12(16)17-3)4-10(13)9(11)6-14-15;1-14-9(13)5-2-7(10)6-4-11-12-8(6)3-5;1-5-3-9-6(2-7)4-8-5;1-6-3-2-4-7-5-6;1-3(2)4;;;;/h5,7,9-15H,6,8H2,1-4H3;5-11H,1-4H3;4-10H,1-3H3,(H,21,22);4-7H,1-3H3;2-4H,1H3,(H,11,12);3-4H,2,7H2,1H3;2-3,5H,1H3;3H,1-2H3;1H;;1H2;/q;;;;;;-1;;;+1;;+2/p-2.
What are the key properties of sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide?
sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide has a molecular weight of 2221.00 g/mol, XLogP of 18.26, 16 rotatable bonds, 3 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide is sourced from PubChem (CID 157453359), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).